Alison Harrod
Impact in
-
- Cancer-related Molecular Pathways
-
- Cancer Genomics and Diagnostics
Papers in
-
- Genomics and Chromatin Dynamics 4
- Advanced biosensing and bioanalysis techniques 2
- Chromatin Remodeling and Cancer 2
- CRISPR and Genetic Engineering 2
- Protein Degradation and Inhibitors 1
- FOXO transcription factor regulation 1
-
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- R. Charles Coombes (5 shared papers)Simak Ali (6 shared papers)Laki Buluwela (3 shared papers)Manikandan Periyasamy (3 shared papers)Jessica A. Downs (3 shared papers)Hetal Patel (2 shared papers)Luca Magnani (2 shared papers)Van T.M. Nguyen (2 shared papers)
- Journals
- Oncogene (2 papers)Cell Reports (2 papers)Molecular Cancer Therapeutics (1 paper)Scientific Reports (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- United KingdomHungarySwitzerland
In The Last Decade
Alison Harrod
8 papers receiving 414 citations
Peers
Comparison fields: 5 of 52
- Oncology 193
- Cancer Research 98
- Molecular Biology 279
- Pulmonary and Respiratory Medicine 110
- Genetics 78
Countries citing papers authored by Alison Harrod
This map shows the geographic impact of Alison Harrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Harrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Harrod more than expected).
Fields of papers citing papers by Alison Harrod
This network shows the impact of papers produced by Alison Harrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Harrod. The network helps show where Alison Harrod may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Harrod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 131 | |
| 2 | 2018 | 111 | |
| 3 | 2015 | 87 | |
| 4 | 2020 | 43 | |
| 5 | 2021 | 18 | |
| 6 | 2022 | 17 | |
| 7 | 2024 | 6 | |
| 8 | 2025 | 3 | |
| 9 | 2025 | 0 |
About Alison Harrod
Alison Harrod is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Plant Science, having authored 9 papers that have together received 416 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (4 papers), Advanced biosensing and bioanalysis techniques (2 papers), MicroRNA in disease regulation (2 papers), Chromatin Remodeling and Cancer (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer Genomics and Diagnostics (1 paper), Protein Degradation and Inhibitors (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Oncology (193 citations), Cancer Research (98 citations), Molecular Biology (279 citations), Pulmonary and Respiratory Medicine (110 citations) and Genetics (78 citations). Alison Harrod has collaborated with scholars based in United Kingdom, Hungary and Switzerland. Frequent co-authors include R. Charles Coombes, Simak Ali, Laki Buluwela, Manikandan Periyasamy, Jessica A. Downs, Hetal Patel, Luca Magnani, Van T.M. Nguyen, Daniela Barsotti Santos and Gergana Metodieva. Their work appears in journals such as Oncogene, Cell Reports, Molecular Cancer Therapeutics, Scientific Reports and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.